Symvess
ACELLULAR TISSUE ENGINEERED VESSEL
Indications and usage 1 INDICATIONS AND USAGE SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.
SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. ( 1 ) Dosage and administration 2 DOSAGE AND ADMINISTRATION For surgical vascular implantation only.
Structured Monograph
Clinical summary
Indications and usage 1 INDICATIONS AND USAGE SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. SYMVESS™ is an acellular tissue engineered vessel indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible. ( 1 ) Dosage and administration 2 DOSAGE AND ADMINISTRATION For surgical vascular implantation only. SYMVESS is administered by surgical implantation to replace the injured extremity artery. The anatomical location and length are decided upon at the discretion of the implanting surgeon and based on the appropriate preoperative clinical evaluation, vessel mapping and/or imaging. ( 2.1 ) SYMVESS may be trimmed to provide the length required for each vascular repair. Additionally, a single SYMVESS can be cut into different lengths and used to repair more than one injured extremity artery in the same patient. Each SYMVESS unit is for administration to a single patient only. ( 2.1 ) 2.1 Dosage SYMVESS is administered by surgical implantation to replace the injured extremity artery. The anatomical location in the extremity and length required should be determined by the surgeon implanting the graft based on the appropriate pre-operative clinical evaluation, vessel mapping and/or imaging, and intra-operative considerations. SYMVESS is provided as follows: 6 mm in internal diameter and 42 cm in length. Once removed from packaging, its usable length is approximately 40 cm. Each package (i.e., box containing Tyvek ® -sealed tray) contains one SYMVESS unit for administration to a single patient only. SYMVESS may be trimmed to provide the length required for the artery replacement. SYMVESS can be trimmed to replace more than one injured extremity artery in the same patient. 2.2 Handling of SYMVESS Supplies: The following supplies are not included in the carton, but may be needed for the handling of SYMVESS: 1) Sterile basin (as needed) – see Step 8 for details 2) Sheath tunneler (as needed) – see Section 2.3 and Step 3 for details SYMVESS is to be handled in an appropriate surgical environment as follows: Step 1: SYMVESS box contains a plastic thermoformed tray with a Tyvek ® lid. Open the box and remove the plastic tray ( Figure 1 ). Figure 1: SYMVESS box and plastic tray Step 2: After removing the tray from the box, check the FreezeAlert temperature indicator ( Figure 2 ) attached to the side of the tray. If a check mark is displayed, SYMVESS has not been exposed to freezing temperatures and can be used. If an “X” is displayed, SYMVESS has been exposed to freezing temperatures and should NOT be used. Figure 2: FreezeAlert Temperature indicator Step 3: Two operators (one sterile operator and one non-sterile operator) are required to remove the sterile packaging bag containing SYMVESS from the plastic tray. Inspect the plastic tray to check for damage which can lead to loss in sterility of the SYMVESS. Do not open the tray for further use if the product is expired or has visible damage. If packaging is intact and within date of acceptable use, the non-sterile operator pulls back the Tyvek ® lid by the corner tab to open the plastic tray containing the sterile packaging bag ( Figure 3a and 3b ). Take careful steps to avoid touching the sterile contents inside the tray ( Figure 3c ). Figure 3a: Non-sterile operator pulls back the Tyvek ® lid by the corner tab Figure 3b: Non-sterile operator opens the plastic tray containing the sterile packaging bag Figure 3c displays the components of SYMVESS within the plastic tray. Figure 3c: SYMVESS with each component Step 4: The non-sterile operator holds the bottom of the plastic tray with one hand and opens the Tyvek ® lid with the other. The sterile operator removes the sterile packaging bag from the tray by grasping the ports (i.e., tubing) at the ends of the sterile packaging bag to remove the sterile packaging bag from the tray ( Figure 4 ). Place the sterile packaging bag on a sterile surface. Figure 4: Sterile operator (grey gown and gloves; left) removes the packaging bag from plastic tray by grasping the ports (tubing) while non-sterile operator (white gloves; right) holds the plastic tray and opens the Tyvek ® lid Step 5 : SYMVESS is suspended in sterile saline inside the packaging. The sterile operator cuts one or both of the outer ports on both ends of the packaging using sterile surgical scissors and drains the sterile saline solution contained within the packaging bag ( Figure 5a , 5b and 5c ). NOTE: If the middle ports or the small outer port are accidentally cut, there is no need for concern. Figure 5a, 5b and 5c: Sterile operator cuts both outer ports one at a time to drain saline solution using surgical scissors Step 6 : Once the saline solut
Boxed Warning
WARNING: GRAFT FAILURE Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. [See Warnings and Precautions (5.1 , 5.2) ] WARNING: GRAFT FAILURE See full prescribing information for complete boxed warning. Loss of SYMVESS integrity due to mid-graft rupture or anastomotic failure can result in life threatening hemorrhage. ( 5.1 , 5.2 )
Monitoring
- • 5 WARNINGS AND PRECAUTIONS Graft Rupture.
- • ( 5.1 ) Anastomotic Failure.
- • ( 5.2 ) Thrombosis.
- • ( 5.3 ) Transmission of Infectious Diseases ( 5.4 ) 5.1 Graft Rupture Vascular graft rupture has occurred in patients treated with SYMVESS [see Clinical Trials Experience (6.1) ] .
Interaction Notes
- • Review official label interaction section.